Jade Biosciences (JBIO) EBIT (2020 - 2026)
Jade Biosciences posted quarterly EBIT of -$43.4 million for Q1 2026, down 85.79% year-on-year from -$305.7 million in Q1 2025, and down 24.2% on a QoQ basis from -$35.0 million in Q4 2025.
Jade Biosciences (JBIO) has 7 years of EBIT data on file, last reported at -$43.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 85.79% year-over-year to -$43.4 million; the trailing twelve-month figure through Mar 2026 stood at -$133.6 million (down 173.75% YoY), and the FY2025 full-year result was -$113.5 million, down 677.47% from the prior year.
- EBIT for Q1 2026 stood at -$43.4 million, down from -$35.0 million in the prior quarter.
- Across five years, EBIT topped out at $43.5 million in Q4 2023 and bottomed at -$43.4 million in Q1 2026.
- The 5-year median for EBIT is -$17.6 million (2023), against an average of -$13.7 million.
- The widest annual swing landed in 2022, when EBIT jumped 421.19%; it then sank 4608.14% in 2025.
- A 5-year view of EBIT shows it stood at $26.6 million in 2022, then surged by 63.85% to $43.5 million in 2023, then sank by 122.67% to -$9.9 million in 2024, then tumbled by 254.54% to -$35.0 million in 2025, then dropped by 24.2% to -$43.4 million in 2026.
- The last three EBIT figures came in at -$43.4 million (Q1 2026), -$35.0 million (Q4 2025), and -$27.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | -43.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.45 Mn |
| Dec 31, 2025 | -34.98 Mn |
| Sep 30, 2025 | -27.40 Mn |
| Jun 30, 2025 | -27.78 Mn |
| Mar 31, 2025 | -23.38 Mn |
| Dec 31, 2024 | -9.87 Mn |
| Sep 30, 2024 | -14.97 Mn |
| Jun 30, 2024 | -590,000.00 |
| Mar 31, 2024 | -24.62 Mn |
| Dec 31, 2023 | 43.51 Mn |
| Sep 30, 2023 | -21.37 Mn |
| Jun 30, 2023 | -20.34 Mn |
| Mar 31, 2023 | -17.64 Mn |
| Dec 31, 2022 | 26.56 Mn |
| Sep 30, 2022 | -14.15 Mn |
| Jun 30, 2022 | -12.22 Mn |
| Mar 31, 2022 | -11.02 Mn |
| Dec 31, 2021 | -8.27 Mn |
| Sep 30, 2021 | -6.20 Mn |
| Jun 30, 2021 | -5.77 Mn |
| Mar 31, 2021 | -2.78 Mn |
| Dec 31, 2020 | -3.66 Mn |
| Sep 30, 2020 | -2.24 Mn |
| Jun 30, 2020 | -1.63 Mn |